 
                                      
                                	
                          
                                
                                Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...
 
                                      
                                	
                          
                                
                                Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...
 
                                      
                                	
                          
                                
                                The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...
 
                                      
                                	
                          
                                
                                We filled 35+ critical HEOR, Market Access, and RWE roles, enabling global product commercia...